Phosphonic Acid

Phosphonic Acid

SCHEMBL649964

CCc1ccccc1CC.O=[PH](O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.52
GABRB2 P47870 4/20 0.52
MGLL Q99685 1/20 0.41
MAPT P10636 2/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
TP53 P04637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CLCN2 P51788 1/20 0.37
CYP2D6 P10635 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL10890655 0.85 GABRA1 (0.60) GABRA1GABRB2MGLLMAPTALDH1A1
Hydrogen Peroxide SCHEMBL11205186 0.85 GABRA1 (0.60) GABRA1GABRB2MGLLMAPTALDH1A1
SCHEMBL25425763 0.85 GABRA1 (0.58) GABRA1GABRB2MGLLMAPTALDH1A1
SCHEMBL36294 0.85 GABRA1 (0.58) GABRA1GABRB2MGLLMAPTALDH1A1
SCHEMBL29390847 0.85 GABRA1 (0.58) GABRA1GABRB2MGLLMAPTALDH1A1
Phosphonic Acid SCHEMBL10824662 0.84 NPC1 (0.47) GABRA1GABRB2ALDH1A1CYP2D6
Phosphonic Acid SCHEMBL649002 0.82 GABRA1 (0.41) GABRA1GABRB2
Ammonia Solution, Strong SCHEMBL2638008 0.82 GABRA1 (0.55) GABRA1GABRB2MGLLMAPTALDH1A1
SCHEMBL14807864 0.82 GABRA1 (0.55) GABRA1GABRB2MGLLMAPTALDH1A1
Benzene SCHEMBL3122858 0.82 TP53 (0.56) GABRA1GABRB2MGLLMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583966-B2 Curable resin, cured product thereof, resin composition, and method for producing curable resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-03-24 US disclosed
US-20250163213-A1 CURABLE RESIN, CURED PRODUCT THEREOF, AND RESIN COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-05-22 US disclosed
US-20250136755-A1 CURABLE RESIN, CURED PRODUCT THEREOF, RESIN COMPOSITION, AND METHOD FOR PRODUCING CURABLE RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-05-01 US disclosed
EP-4480986-A1 CURABLE RESIN, CURED PRODUCT OF SAME, AND RESIN COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-12-25 EP disclosed
EP-4480985-A1 CURABLE RESIN, CURED PRODUCT THEREOF, RESIN COMPOSITION, AND PRODUCTION METHOD FOR CURABLE RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-12-25 EP disclosed
US-11760840-B2 Thermoplastic resin composition and molded article thereof TEIJIN LIMITED (JP) 2023-09-19 US disclosed
EP-2977409-B2 GLASS-FIBER-REINFORCED POLYCARBONATE RESIN COMPOSITION TEIJIN LTD (JP) 2022-12-07 EP disclosed
EP-3604440-B1 POLYCARBONATE RESIN COMPOSITION AND OPTICAL LENS USING SAME MITSUBISHI GAS CHEMICAL CO (JP) 2022-10-26 EP disclosed
WO-2022164084-A1 POLYCARBONATE AND METHOD FOR PREPARING SAME 주식회사 엘지화학 2022-08-04 WO disclosed
WO-2022164074-A1 POLYCARBONATE, AND METHOD FOR PREPARING SAME 주식회사 엘지화학 2022-08-04 WO disclosed
EP-2067809-A1 POLYCARBONATE AND METHOD FOR PRODUCING THE SAME Teijin Chemicals, Ltd. (JP) 2009-06-10 EP disclosed
EP-2048201-A1 RESIN COMPOSITION Teijin Chemicals, Ltd. (JP) 2009-04-15 EP disclosed
US-7244804-B2 Having excellent light resistance, heat resistance and color stability, prepared from a 9,9-bis(4-hydroxyphenyl)fluorene and a bisphenol; may contain a benzoxazine ultraviolet absorber TEIJIN CHEMICALS, LTD. (JP) 2007-07-17 US disclosed
US-7148313-B2 Polycarbonate resin composition and molded articles thereof TEIJIN CHEMICALS, LTD. (JP) 2006-12-12 US disclosed
US-20050250930-A1 Polycarbonate copolymer, resin composition, and molded article TEIJIN CHEMICALS LTD. (JP) 2005-11-10 US disclosed
US-20050215750-A1 Polycarbonate resin composition and molded articles thereof TEIJIN CHEMICALS, LTD. (JP) 2005-09-29 US disclosed
EP-1566396-A1 POLYCARBONATE COPOLYMER, RESIN COMPOSITION, AND MOLDED ARTICLE Teijin Chemicals, Ltd. (JP) 2005-08-24 EP disclosed
US-6355767-B1 BLEND WITH THERMOPLASTIC GRAFT POLYMER COMPRISING VINYL CYANIDE, VINYLAROMATIC AND DIENE COMONOMERS; HEAT RESISTANCE, TRANSPARENCY, NONHYDROLYZING, IMPACT STRENGTH TEIJIN CHEMICALS, LTD (JP) 2002-03-12 US disclosed
US-5562820-A Process for purifying water AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1996-10-08 US disclosed
US-5449467-A Process for purifying water DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1995-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583966-B2 Curable resin, cured product thereof, resin composition, and method for producing curable resin ARL1, ASH2L, SEM1 GABRA1 1307/4885GABRB2 2602/4885MGLL 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.